The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia

被引:4
|
作者
Thayabaran, Darmiga [1 ]
Tsui, Anson P. T. [2 ]
Ebmeier, Stefan [3 ]
Cegla, Jaimini [1 ,4 ]
David, Alessia [1 ,5 ]
Jones, Ben [1 ,4 ]
机构
[1] Imperial Coll Healthcare NHS Trust, London, England
[2] Imperial Coll London, London, England
[3] Imperial Coll London, Dept Infect Dis, London, England
[4] Imperial Coll London, Dept Metab Digest & Reprod, London, England
[5] Imperial Coll London, Dept Life Sci, London, England
关键词
Familial hypercholesterolaemia; LDL-cholesterol; Lipoprotein(a); Simon Broome criteria; Dutch Lipid Clinic Network criteria; DENSITY-LIPOPROTEIN CHOLESTEROL; HUMAN-PLASMA; KRINGLE;
D O I
10.1016/j.jacl.2023.01.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Familial hypercholesterolaemia (FH) diagnostic tools help prioritise patients for ge-netic testing and include LDL-C estimates commonly calculated using the Friedewald equation. How-ever, cholesterol contributions from lipoprotein(a) (Lp(a)) can overestimate 'true' LDL-C, leading to potentially inappropriate clinical FH diagnosis.Objective: To assess how adjusting LDL-C for Lp(a)-cholesterol affects FH diagnoses using Simon Broome (SB) and Dutch Lipid Clinic Network (DLCN) criteria.Methods: Adults referred to a tertiary lipid clinic in London, UK were included if they had un-dergone FH genetic testing based on SB or DLCN criteria. LDL-C was adjusted for Lp(a)-cholesterol using estimated cholesterol contents of 17.3%, 30% and 45%, and the effects of these adjustments on reclassification to 'unlikely' FH and diagnostic accuracy were determined.Results: Depending on the estimated cholesterol content applied, LDL-C adjustment reclassified 8-23% and 6-17% of patients to 'unlikely' FH using SB and DLCN criteria, respectively. The highest reclassification rates were observed following 45% adjustment in mutation-negative patients with higher Lp(a) levels. This led to an improvement in diagnostic accuracy (46% to 57% with SB, and 32% to 44% with DLCN following 45% adjustment) through increased specificity. However all adjustment factors led to erroneous reclassification of mutation-positive patients to 'unlikely' FH. Conclusion: LDL-C adjustment for Lp(a)-cholesterol improves the accuracy of clinical FH diagnostic tools. Adopting this approach would reduce unnecessary genetic testing but also incorrectly reclassify mutation-positive patients. Health economic analysis is needed to balance the risks of over-and under -diagnosis before LDL-C adjustments for Lp(a) can be recommended.(c) 2023 National Lipid Association. Published by Elsevier Inc. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:244 / 254
页数:11
相关论文
共 50 条
  • [1] The effect of adjusting LDL-cholesterol for Lipoprotein(a)-cholesterol on the diagnosis of Familial Hypercholesterolaemia
    Thayabaran, D.
    Tsui, A. P. T.
    Ebmeier, S. J.
    Cegla, J.
    David, A.
    Jones, B.
    ATHEROSCLEROSIS PLUS, 2022, 49 : S3 - S3
  • [2] RELATIONSHIP BETWEEN MEASUREMENTS OF NON-HDL-CHOLESTEROL AND LDL-CHOLESTEROL IN FAMILIAL HYPERCHOLESTEROLAEMIA
    Abreu, J.
    Haralambos, K.
    Ashfield-Watt, P.
    Edwards, R.
    Gingell, R.
    Townsend, D.
    Datta, D.
    McDowell, I. F. W.
    ATHEROSCLEROSIS, 2016, 245 : E247 - E247
  • [4] INCLISIRAN REDUCES LDL-CHOLESTEROL INDEPENDENT OF GENOTYPE IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
    Raal, F. J.
    Kallend, D.
    Ray, K. K.
    Turner, T. A.
    Koenig, W.
    Wright, R. S.
    Wijngaard, P. L.
    Curcio, D.
    Jaros, M. J.
    Leiter, L. A.
    Landmesser, U.
    Kastelein, J. J.
    ATHEROSCLEROSIS, 2020, 315 : E7 - E8
  • [5] ERRORS IN THE IMPUTATION OF LDL-CHOLESTEROL WHEN MAKING A PHENOTYPIC DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLAEMIA IN DRUG TREATED PATIENTS
    Ellis, K.
    Pang, J.
    Watts, G.
    ATHEROSCLEROSIS, 2018, 275 : E99 - E99
  • [6] The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia
    Yeang, Calvin
    Willeit, Peter
    Tsimikas, Sotirios
    CURRENT OPINION IN LIPIDOLOGY, 2020, 31 (06) : 305 - 312
  • [7] Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia
    Perez de Isla, Leopoldo
    Watts, Gerald F.
    Alonso, Rodrigo
    Luis Diaz-Diaz, Jose
    Muniz-Grijalvo, Ovidio
    Zambon, Daniel
    Fuentes, Francisco
    de Andres, Raimundo
    Padro, Teresa
    Lopez-Miranda, Jose
    Mata, Pedro
    EUROPEAN HEART JOURNAL, 2021, 42 (22) : 2201 - 2211
  • [8] LDL-CHOLESTEROL CORRECTED FOR LP(A)-CHOLESTEROL, RISK THRESHOLDS AND CARDIOVASCULAR EVENTS
    Willeit, P.
    Yeang, C.
    Moriarty, P. M.
    Tschiderer, L.
    Varvel, S. A.
    Mcconnell, J. P.
    Tsimikas, S.
    ATHEROSCLEROSIS, 2020, 315 : E34 - E35
  • [9] GENETIC DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA (FH) AND LDL-CHOLESTEROL GOAL ACHIEVEMENT
    Alonso, R.
    Villar, J.
    Fuentes, F.
    Zambon, D.
    Mata, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
    Iyen, Barbara
    Akyea, Ralph K.
    Weng, Stephen
    Kai, Joe
    Qureshi, Nadeem
    OPEN HEART, 2021, 8 (02):